# 119-hr-8630: PEAT Act of 2026

119-hr-8630, PEAT Act of 2026, is a 119th Congress bill sponsored by Rep. Rulli, Michael A. [R-OH-6] (R-OH); status introduced; PRIA reads it as touching household money (as of 2026-09-21).

- Canonical: https://policyrisk.com/legislation/119-hr-8630
- As of: 2026-09-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-8630
- Congress: 119
- Title: PEAT Act of 2026
- Status: introduced
- Introduced: 2026-04-30
- Sponsor: Rep. Rulli, Michael A. [R-OH-6] (R-OH)
- Cosponsors: 12
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-09-21

## Summary

**Prevents reclassifying a biologic as a 'biological product' solely because it includes a clinically inactive protein.** The bill would amend 42 U.S.C. 262(i)(1) to add a new subparagraph that bars treating a biologic as a biological product based only on a clinically inactive protein, preserve the existing definitional anchor, make a minor punctuation correction, and would not create new funding or change eligibility, benefits, enforcement, or program structures.

## Cosponsors (12)

- Rep. Harshbarger, Diana [R-TN-1] (R-TN), 2026-04-30T00:00:00.000Z
- Rep. Luttrell, Morgan [R-TX-8] (R-TX), 2026-05-13T00:00:00.000Z
- Rep. Babin, Brian [R-TX-36] (R-TX), 2026-05-14T00:00:00.000Z
- Rep. Kennedy, Mike [R-UT-3] (R-UT), 2026-05-15T00:00:00.000Z
- Rep. Carter, John R. [R-TX-31] (R-TX), 2026-06-02T00:00:00.000Z
- Rep. Hamadeh, Abraham J. [R-AZ-8] (R-AZ), 2026-06-08T00:00:00.000Z
- Rep. Weber, Randy K. Sr. [R-TX-14] (R-TX), 2026-06-23T00:00:00.000Z
- Rep. Nehls, Troy E. [R-TX-22] (R-TX), 2026-06-24T00:00:00.000Z
- Rep. McCaul, Michael T. [R-TX-10] (R-TX), 2026-06-29T00:00:00.000Z
- Rep. Carter, Earl L. "Buddy" [R-GA-1] (R-GA), 2026-07-16T00:00:00.000Z
- Rep. Khanna, Ro [D-CA-17] (D-CA), 2026-07-20T00:00:00.000Z
- Rep. Langworthy, Nicholas A. [R-NY-23] (R-NY), 2026-08-13T00:00:00.000Z

## Provisions PRIA read

- Biologic makers shielded from reclassification: benefit, low. This bill would stop regulators from treating some biologic medicines as "biological products" just because they contain a clinically inactive protein. It would do this by amending 42 U.S.C. 262(i)(1) to add that prohibition. The change would mainly affect companies that make or sell those biologic…

## Related bills

- 119-hres-719: Honoring the life and legacy of Charles Charlie James Kirk.
- 119-hr-404: Hearing Protection Act
- 119-hr-425: Repealing Big Brother Overreach Act
- 119-hr-909: Crime Victims Fund Stabilization Act of 2025
- 119-hr-38: Constitutional Concealed Carry Reciprocity Act of 2025
- 119-hr-1628: 761st Tank Battalion Congressional Gold Medal Act

## Sources
- [119-hr-8630 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/8630)

## Related
- [119-hres-719: Honoring the life and legacy of Charles Charlie James Kirk.](https://policyrisk.com/legislation/119-hres-719)
- [119-hr-404: Hearing Protection Act](https://policyrisk.com/legislation/119-hr-404)
- [119-hr-425: Repealing Big Brother Overreach Act](https://policyrisk.com/legislation/119-hr-425)
- [119-hr-909: Crime Victims Fund Stabilization Act of 2025](https://policyrisk.com/legislation/119-hr-909)
- [119-hr-38: Constitutional Concealed Carry Reciprocity Act of 2025](https://policyrisk.com/legislation/119-hr-38)
- [119-hr-1628: 761st Tank Battalion Congressional Gold Medal Act](https://policyrisk.com/legislation/119-hr-1628)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-8630 (as of 2026-09-21).